Treatment of Hypertension in Adults Over Age 60 to Higher vs. Lower Targets: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

Blood Pressure (G09.330.380.076); Pharmacologic Actions (D27.505); Angiotensin-Converting Enzyme Inhibitors (D27.505.519.389.745.085); Angiotensin Receptor Antagonists (D27.505.519.162); Antihypertensive Agents (D27.505.954.411.162); Calcium Channel Blockers (D27.505.954.411.192); Calcium Channel Blockers (D27.505.519.562.249); Adrenergic beta-1 Receptor Antagonists (D27.505.696.577.050.200.200.100); Adrenergic beta-1 Receptor Agonists (D27.505.696.577.050.100.200.100); Adrenergic beta-1 Receptor Antagonists (D27.505.519.625.050.200.200.100); Adrenergic beta-1 Receptor Agonists (D27.505.519.625.050.100.200.100); Adrenergic beta-2 Receptor Agonists (D27.505.519.625.050.100.200.200); Adrenergic beta-2 Receptor Antagonists (D27.505.519.625.050.200.200.200); Adrenergic beta-2 Receptor Agonists (D27.505.696.577.050.100.200.200); Adrenergic beta-2 Receptor Antagonists (D27.505.696.577.050.200.200.200); Adrenergic beta-3 Receptor Agonists (D27.505.519.625.050.100.200.300); Adrenergic beta-3 Receptor Agonists (D27.505.696.577.050.100.200.300); Adrenergic beta-3 Receptor Antagonists (D27.505.519.625.050.200.200.300); Adrenergic beta-3 Receptor Antagonists (D27.505.696.577.050.200.200.300); Hypertension (C14.907.489); Blood Pressure (E01.370.600.875.249)